Erasca, Inc. - ERAS
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | T. Rowe Price Investment Management, Inc. | 5.7% | 16,111,414 | View |
| Jan 14, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 5.3% | 15,159,095 | View |
| Jan 14, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 5.3% | 15,159,095 | View |
| Jan 14, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 5.3% | 15,159,095 | View |
| Jan 14, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 4.7% | 13,377,027 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Logos Global Management LP | 4.8% | 13,600,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Logos Global Management GP LLC | 4.8% | 13,600,000 | View |
| Nov 14, 2025 | SCHEDULE 13G/A | Arsani William | 4.8% | 13,600,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.